Vetmedin 3.5mg/ml Oral Solution For Dogs 42 mL Bottle

Indicated for:

• The treatment of canine congestive heart failure (CHF) originating from dilated cardiomyopathy (DCM) or valvular insufficiency (mitral and/ or tricuspid regurgitation).
• The treatment of pre-clinical DCM in large breed dogs. When used in cases of preclinical DCM in large breed dogs, pimodendan significantly prolonged the time to the onset of CHF or sudden death, and also resulted in prolongation of the time to death due to all causes.
• Doberman Pinscher dogs with preclinical DCM treated with pimobendan also demonstrated a significant reduction in Left Ventricular Internal Diameter in both systole and diastole (LVIDs/d) in response to therapy.
• For the treatment of dogs with evidence of increased heart size secondary to asymptomatic (preclinical) myxomatous mitral valve disease to delay the onset of clinical symptoms of heart failure, to reduce heart size and to increase survival time.

Indication:

For the treatment of canine congestive heart failure originating from dilated cardiomyopathy or valvular insufficiency ( mitral and/or tricuspid regurgitation).

Active Ingredient:

Pimobendan 3.5mg/mL